+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Steroid Injections Market by Product Type, Administration Route, Distribution Channel, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6012190
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Steroid Injections Market grew from USD 3.80 billion in 2023 to USD 4.29 billion in 2024. It is expected to continue growing at a CAGR of 13.54%, reaching USD 9.25 billion by 2030.

Steroid injections, a critical intervention in pain management and inflammation reduction, carry substantial scope in medical applications, particularly in treating conditions such as arthritis, tendonitis, and bursitis. They act swiftly to decrease inflammation and facilitate rehabilitation of ailments in joints, muscles, and connective tissues. Traditionally administered in settings such as hospitals and outpatient clinics, these injections have found growing use across both pharmaceutical and sports medicine sectors, due to their efficient therapeutic effects. The burgeoning geriatric population, coupled with increasing incidences of chronic conditions, acts as a significant driver for market growth, supported by advancements in healthcare infrastructure and greater accessibility to advanced medical treatments. Technological innovations in formulation and delivery techniques present alluring growth opportunities, such as the development of novel steroid compounds with prolonged efficacy and reduced side effects. However, limitations persist, including potential side effects and dependency, alongside regulatory scrutiny and high treatment costs, which pose challenges to market expansion. Furthermore, patient apprehension regarding invasive procedures and alternative pain management methods can constrain demand. To navigate these challenges, businesses may focus on non-invasive delivery systems and patient-centric innovations, developing education campaigns to alleviate concerns regarding side effects. Research can be expanded into biodegradable formulation techniques, improving patient compliance and treatment outcomes. The market remains dynamic, with significant potential for growth through strategic partnerships and tapping into emerging markets, where demand for healthcare interventions is on the rise. Engaging in collaborations with academic institutions for clinical trials can also spur product innovation, blending clinical expertise with cutting-edge biotechnology. Exploring these avenues could bolster market presence and enhance competitive advantage, promoting growth while aligning with patient safety and efficacy standards.

Understanding Market Dynamics in the Steroid Injections Market

The Steroid Injections Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing geriatric population along with occurrences of orthopedic disorders
    • Popularity of bodybuilding among young people
  • Market Restraints
    • Stringent regulation for steroid injection usage
  • Market Opportunities
    • Growing attraction towards plastic surgeries
    • Introduction and approval of the steroid injections
  • Market Challenges
    • Harmful side effects associated with the consumption of steroids

Exploring Porter’s Five Forces for the Steroid Injections Market

Porter’s Five Forces framework further strengthens the insights of the Steroid Injections Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Steroid Injections Market

External macro-environmental factors deeply influence the performance of the Steroid Injections Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Steroid Injections Market

The Steroid Injections Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Steroid Injections Market

The Steroid Injections Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Steroid Injections Market

The Steroid Injections Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Steroid Injections Market, highlighting leading vendors and their innovative profiles. These include Actiza Pharmaceutical Private Limited, AdvaCare Pharma, ANI Pharmaceuticals, Inc.,, Bristol-Myers Squibb Company, Farmabios GmbH, Flagship Biotech International Private Limited., Flexion Therapeutics Inc., GSK plc, Health Biotech Limited, Intrapharm Laboratories, Merck & Co., Inc., Merit Healthcare International Inc., Mylan N.V., Novartis AG, and Perrigo Company plc.

Market Segmentation & Coverage

This research report categorizes the Steroid Injections Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Cortisone
    • Hydrocortisone
    • Methylprednisolone
    • Triamcinolone
  • Administration Route
    • Epidural
    • Intra-Articular
    • Intramuscular
    • Intravenous
  • Distribution Channel
    • Hospital Pharmacy
    • Retail Pharmacy
    • Specialty Clinics
  • Application
    • Ankylosing Spondylitis
    • Back pain
    • Bursitis
    • Cancer
    • Gout
    • Osteoarthritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing geriatric population along with occurrences of orthopedic disorders
5.1.1.2. Popularity of bodybuilding among young people
5.1.2. Restraints
5.1.2.1. Stringent regulation for steroid injection usage
5.1.3. Opportunities
5.1.3.1. Growing attraction towards plastic surgeries
5.1.3.2. Introduction and approval of the steroid injections
5.1.4. Challenges
5.1.4.1. Harmful side effects associated with the consumption of steroids
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Steroid Injections Market, by Product Type
6.1. Introduction
6.2. Cortisone
6.3. Hydrocortisone
6.4. Methylprednisolone
6.5. Triamcinolone
7. Steroid Injections Market, by Administration Route
7.1. Introduction
7.2. Epidural
7.3. Intra-Articular
7.4. Intramuscular
7.5. Intravenous
8. Steroid Injections Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Retail Pharmacy
8.4. Specialty Clinics
9. Steroid Injections Market, by Application
9.1. Introduction
9.2. Ankylosing Spondylitis
9.3. Back pain
9.4. Bursitis
9.5. Cancer
9.6. Gout
9.7. Osteoarthritis
9.8. Psoriatic Arthritis
9.9. Rheumatoid Arthritis
10. Americas Steroid Injections Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Steroid Injections Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Steroid Injections Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. STEROID INJECTIONS MARKET RESEARCH PROCESS
FIGURE 2. STEROID INJECTIONS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. STEROID INJECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. STEROID INJECTIONS MARKET DYNAMICS
TABLE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CORTISONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GOUT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. CANADA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 45. CANADA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. CANADA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. MEXICO STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CHINA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CHINA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 67. CHINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. CHINA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. INDIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. INDIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 71. INDIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. INDIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. JAPAN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. JAPAN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 79. JAPAN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. JAPAN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. THAILAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. THAILAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 103. THAILAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. THAILAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. DENMARK STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. DENMARK STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 116. DENMARK STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. DENMARK STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. EGYPT STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. EGYPT STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 120. EGYPT STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. EGYPT STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. FINLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 124. FINLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. FINLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. FRANCE STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. FRANCE STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. GERMANY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 132. GERMANY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. GERMANY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. ITALY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. ITALY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 140. ITALY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. ITALY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. NORWAY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. NORWAY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 152. NORWAY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. NORWAY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. POLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. POLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 156. POLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. POLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. QATAR STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. QATAR STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 160. QATAR STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. QATAR STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SPAIN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 176. SPAIN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. SPAIN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. TURKEY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. TURKEY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 188. TURKEY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. TURKEY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 199. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Steroid Injections market, which are profiled in this report, include:
  • Actiza Pharmaceutical Private Limited
  • AdvaCare Pharma
  • ANI Pharmaceuticals, Inc.,
  • Bristol-Myers Squibb Company
  • Farmabios GmbH
  • Flagship Biotech International Private Limited.
  • Flexion Therapeutics Inc.
  • GSK plc
  • Health Biotech Limited
  • Intrapharm Laboratories
  • Merck & Co., Inc.
  • Merit Healthcare International Inc.
  • Mylan N.V.
  • Novartis AG
  • Perrigo Company plc

Methodology

Loading
LOADING...

Table Information